IA
COGT icon

IFP Advisors’s Cogent Biosciences COGT Stock Holding History

IFP Advisors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86K Sell
2,221
-3
-0.1% -$105 ﹤0.01% 2080
2026
Q1 		$85.6K Buy
2,224
+2,200
+9,167% +$81.2K ﹤0.01% 1946
2025
Q4 		$852 Buy
24
+7
+41% +$197 ﹤0.01% 4119
2025
Q3 		$244 Buy
+17
New +$201 ﹤0.01% 4356
2025
Q2 		– Sell
-8
Closed -$44 – 4083
2025
Q1 		$48 Buy
+8
New +$63 ﹤0.01% 4030
2024
Q4 		– Hold
0
– – – 3236
2023
Q1 		– Sell
-200
Closed -$2K – 3560
2022
Q4 		$2K Hold
200
– – ﹤0.01% 4130
2022
Q3 		$2K Hold
200
– – ﹤0.01% 4331
2022
Q2 		$2K Hold
200
– – ﹤0.01% 4097
2022
Q1 		$2K Buy
+200
New +$1.39K ﹤0.01% 4097

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

IFP Advisors's COGT Position: Q2 2026 in Review

IFP Advisors reduced its Cogent Biosciences (COGT) stake by 0.13% in Q2 2026, selling an estimated $105 and leaving 2,221 shares worth $86K. The position accounts for ﹤0.01% of the portfolio, ranked #2080.

IFP Advisors first reported a position in COGT in Q1 2022 and has held it in 9 quarters since. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • IFP Advisors held 2,221 shares of Cogent Biosciences worth $86K as of Q2 2026.
  • IFP Advisors sold 3 Cogent Biosciences shares in Q2 2026, an estimated $105.
  • Cogent Biosciences made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2080 holding.
  • IFP Advisors first reported a position in Cogent Biosciences in Q1 2022 and has held it in 9 quarters since.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.